Kenneth R. Deans Jr.
Carolina del Sur
Kenneth R. Deans Jr. es colaborador de The American Quorum. Con más de 30 años de experiencia en puestos de liderazgo en los sectores de la salud, la tecnología y la educación, aporta una perspectiva independiente y basada en su amplia experiencia a los temas que marcan el rumbo de Estados Unidos.
Tecnología
Apple Patches Two Actively Exploited Zero-Days Across iPhones, iPads and Macs
Salud
PACT Act Becomes Law, Expanding Toxic-Exposure Care and Benefits for Millions of Veterans
Tecnología
Biden Signs $52.7 Billion Semiconductor Push as CHIPS and Science Act Becomes Law
Salud
U.S. Declares Monkeypox a Public Health Emergency as Cases Exceed 6,600 and Vaccine Demand Strains Supply
Tecnología
Amazon Agrees to Buy Roomba Maker iRobot for $1.7 Billion, Deepening Its Push Into Connected Homes
Salud
HHS Proposes Restoring ACA Civil-Rights Protections for LGBTQ Patients, Reproductive Care and Language Access
Tecnología
House Passes CHIPS and Science Act 243-187 After 64-33 Senate Vote, Sending $52 Billion Semiconductor Push to Biden
Salud
New York Confirms First U.S. Polio Case Since 2013 as Unvaccinated Rockland County Adult Develops Paralysis
Tecnología
Amazon Agrees to Buy One Medical for $3.9 Billion, Expanding From Pharmacy and Telehealth Into Primary-Care Clinics
Salud
FDA Authorizes Novavax COVID-19 Vaccine for U.S. Adults, Adding First Protein-Based Option
Tecnología
Twitter Sues Musk to Enforce $44 Billion Deal, Asking Delaware Court to Order Closing at $54.20 a Share
Salud
FDA Lets Pharmacists Prescribe Paxlovid, Expanding Access With Kidney, Liver and Drug-Interaction Safeguards
Tecnología
Musk Moves to Terminate $44 Billion Twitter Deal, Alleging Data and Representation Breaches as Twitter Vows Enforcement
Salud
FDA Tells Vaccine Makers to Target Omicron BA.4 and BA.5 in Bivalent COVID-19 Boosters for Fall
Tecnología
Google Will Delete Location History for Abortion Clinics and Other Sensitive Sites After Roe Reversal
Salud
FDA Orders Juul Off U.S. Market, Citing Insufficient and Conflicting Toxicology Data
Tecnología
Twitter Board Recommends $44 Billion Musk Sale at $54.20 a Share as Bot Dispute Hangs Over Deal
423 stories